Licensing-First Approach, Commercial-Ready Results
Genvor builds strategic partnerships that create mutual competitive advantages across both agriculture and human health & wellness. In agriculture, our licensing-first model enables industry leaders to access validated peptide technology with protected market rights, while we leverage their regulatory expertise and commercialization capabilities. In human health, we are pursuing partnerships with credentialed wellness leaders and elite athletes who bring deep expertise in recovery and performance optimization. We are proud to offer partners ready-to-deploy, capital-efficient licensing and co-development opportunities across agriculture, animal feed, environmental, and consumer health sectors.
Early partnerships with purpose
We’ve secured foundational alliances that support real-world testing, regulatory progress, and the path to commercialization.
USDA
Public-Sector Partnership Advancing Peptide Innovation
Genvor’s Cooperative Research and Development Agreement (CRADA) with the USDA targets aflatoxin-producing pathogens in corn, supporting the development of disease-resistant crops and advancing peptide commercialization across key markets.
Bayer
Bayer Awards Genvor the 2024 Golden Ticket
Genvor’s partnership with Bayer, through its Golden Ticket award, supports the advancement of peptide-based crop protection with access to lab space, technical mentorship, and commercialization pathways at LifeHub California @AgStart.
Let’s Build the Future Together
Genvor partners across agriculture and human health & wellness. Our licensing-first model and DTC wellness strategy are built for real-world deployment and long-term success.
Interested in partnering across agriculture or health & wellness? Let’s talk.
Email: licensing@genvor.com
Phone: (715)-903-6473